Glenn Muir's Trading History
| CTKBCytek Biosciences | Aug 20, 2026 | Director | Uninformative Buy | 14.41K | $18.92K | |
| STIMNeuronetics | May 29, 2026 | Director | Uninformative Buy | ― | $904.09K | |
| RGENRepligen | May 18, 2026 | Director | Uninformative Buy | ― | $7.09M | |
| GTHXG1 Therapeutics | Sep 18, 2024 | ― | Uninformative Sell | ― | $0.00 | |
| LFWDLifeward | Dec 31, 2015 | Director | Uninformative Buy | ― | $35.84K | |
| HOLXHologic | May 12, 2014 | ― | Informative Sell | 1.21M | $61.97M |
You May Also Like
Glenn Muir insider profile FAQ
What is the percentage of profitable transactions made by Glenn Muir?
The percentage of profitable transactions made by Glenn Muir is 63%.
What is the average return per transaction made by Glenn Muir?
The average return per transaction made by Glenn Muir is 114.80%.
What stocks does Glenn Muir hold?
Glenn Muir holds: CTKB, RGEN, LFWD, GTHX, STIM, HOLX stocks.
What was Glenn Muir’s latest transaction?
Glenn Muir’s latest transaction was an Uninformative Buy of $14.41K.
What was Glenn Muir's most profitable transaction?
Glenn Muir’s most profitable transaction was an Informative Buy of STIM stock on September 6, 2024. The return on the trade was 316.70%.
What is Glenn Muir's role in Cytek Biosciences?
Glenn Muir's role in Cytek Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.